182 related articles for article (PubMed ID: 38528055)
1. Decreased calcium permeability caused by biallelic TRPV5 mutation leads to autosomal recessive renal calcium-wasting hypercalciuria.
Guleray Lafci N; van Goor M; Cetinkaya S; van der Wijst J; Acun M; Kurt Colak F; Cetinkaya A; Hoenderop J
Eur J Hum Genet; 2024 Mar; ():. PubMed ID: 38528055
[TBL] [Abstract][Full Text] [Related]
2. Autosomal dominant hypercalciuria in a mouse model due to a mutation of the epithelial calcium channel, TRPV5.
Loh NY; Bentley L; Dimke H; Verkaart S; Tammaro P; Gorvin CM; Stechman MJ; Ahmad BN; Hannan FM; Piret SE; Evans H; Bellantuono I; Hough TA; Fraser WD; Hoenderop JG; Ashcroft FM; Brown SD; Bindels RJ; Cox RD; Thakker RV
PLoS One; 2013; 8(1):e55412. PubMed ID: 23383183
[TBL] [Abstract][Full Text] [Related]
3. TRPV5 gene polymorphisms in renal hypercalciuria.
Renkema KY; Lee K; Topala CN; Goossens M; Houillier P; Bindels RJ; Hoenderop JG
Nephrol Dial Transplant; 2009 Jun; 24(6):1919-24. PubMed ID: 19131347
[TBL] [Abstract][Full Text] [Related]
4. WNK4 enhances TRPV5-mediated calcium transport: potential role in hypercalciuria of familial hyperkalemic hypertension caused by gene mutation of WNK4.
Jiang Y; Ferguson WB; Peng JB
Am J Physiol Renal Physiol; 2007 Feb; 292(2):F545-54. PubMed ID: 17018846
[TBL] [Abstract][Full Text] [Related]
5. The expression and implication of TRPV5, Calbindin-D28k and NCX1 in idiopathic hypercalciuria.
Wang S; Hu D; Xi Q; Su S; Bai J; Liu J; Ye Z
J Huazhong Univ Sci Technolog Med Sci; 2008 Oct; 28(5):580-3. PubMed ID: 18846343
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of Ca(2+) and Mg(2+) transport proteins in the kidney explains tacrolimus (FK506)-induced hypercalciuria and hypomagnesemia.
Nijenhuis T; Hoenderop JG; Bindels RJ
J Am Soc Nephrol; 2004 Mar; 15(3):549-57. PubMed ID: 14978156
[TBL] [Abstract][Full Text] [Related]
7. SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis.
Bergwitz C; Roslin NM; Tieder M; Loredo-Osti JC; Bastepe M; Abu-Zahra H; Frappier D; Burkett K; Carpenter TO; Anderson D; Garabedian M; Sermet I; Fujiwara TM; Morgan K; Tenenhouse HS; Juppner H
Am J Hum Genet; 2006 Feb; 78(2):179-92. PubMed ID: 16358214
[TBL] [Abstract][Full Text] [Related]
8. ADCY10 frameshift variant leading to severe recessive asthenozoospermia and segregating with absorptive hypercalciuria.
Akbari A; Pipitone GB; Anvar Z; Jaafarinia M; Ferrari M; Carrera P; Totonchi M
Hum Reprod; 2019 Jun; 34(6):1155-1164. PubMed ID: 31119281
[TBL] [Abstract][Full Text] [Related]
9. A helix-breaking mutation in the epithelial Ca(2+) channel TRPV5 leads to reduced Ca(2+)-dependent inactivation.
Lee KP; Nair AV; Grimm C; van Zeeland F; Heller S; Bindels RJ; Hoenderop JG
Cell Calcium; 2010 Nov; 48(5):275-87. PubMed ID: 21035851
[TBL] [Abstract][Full Text] [Related]
10. A novel loss-of-function mutation, Gln459Arg, of the calcium-sensing receptor gene associated with apparent autosomal recessive inheritance of familial hypocalciuric hypercalcemia.
Lietman SA; Tenenbaum-Rakover Y; Jap TS; Yi-Chi W; De-Ming Y; Ding C; Kussiny N; Levine MA
J Clin Endocrinol Metab; 2009 Nov; 94(11):4372-9. PubMed ID: 19789209
[TBL] [Abstract][Full Text] [Related]
11. TRPV5 in renal tubular calcium handling and its potential relevance for nephrolithiasis.
van der Wijst J; van Goor MK; Schreuder MF; Hoenderop JG
Kidney Int; 2019 Dec; 96(6):1283-1291. PubMed ID: 31471161
[TBL] [Abstract][Full Text] [Related]
12. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: unusual clinical associations and novel claudin16 mutation in an Egyptian family.
Al-Haggar M; Bakr A; Tajima T; Fujieda K; Hammad A; Soliman O; Darwish A; Al-Said A; Yahia S; Abdel-Hady D
Clin Exp Nephrol; 2009 Aug; 13(4):288-294. PubMed ID: 19165416
[TBL] [Abstract][Full Text] [Related]
13. Furosemide rescues hypercalciuria in familial hypomagnesaemia with hypercalciuria and nephrocalcinosis model.
Kriuchkova N; Breiderhoff T; Müller D; Yilmaz DE; Demirci H; Drewell H; Günzel D; Himmerkus N; Bleich M; Persson PB; Mutig K
Acta Physiol (Oxf); 2023 Mar; 237(3):e13927. PubMed ID: 36606514
[TBL] [Abstract][Full Text] [Related]
14. Mucin-1 Increases Renal TRPV5 Activity In Vitro, and Urinary Level Associates with Calcium Nephrolithiasis in Patients.
Nie M; Bal MS; Yang Z; Liu J; Rivera C; Wenzel A; Beck BB; Sakhaee K; Marciano DK; Wolf MT
J Am Soc Nephrol; 2016 Nov; 27(11):3447-3458. PubMed ID: 27036738
[TBL] [Abstract][Full Text] [Related]
15. Fanconi-Bickel syndrome and autosomal recessive proximal tubulopathy with hypercalciuria (ARPTH) are allelic variants caused by GLUT2 mutations.
Mannstadt M; Magen D; Segawa H; Stanley T; Sharma A; Sasaki S; Bergwitz C; Mounien L; Boepple P; Thorens B; Zelikovic I; Jüppner H
J Clin Endocrinol Metab; 2012 Oct; 97(10):E1978-86. PubMed ID: 22865906
[TBL] [Abstract][Full Text] [Related]
16. TRPV5: a Ca(2+) channel for the fine-tuning of Ca(2+) reabsorption.
Na T; Peng JB
Handb Exp Pharmacol; 2014; 222():321-57. PubMed ID: 24756712
[TBL] [Abstract][Full Text] [Related]
17. Autosomal recessive renal proximal tubulopathy and hypercalciuria: a new syndrome.
Magen D; Adler L; Mandel H; Efrati E; Zelikovic I
Am J Kidney Dis; 2004 Apr; 43(4):600-6. PubMed ID: 15042536
[TBL] [Abstract][Full Text] [Related]
18. SaRNA-mediated activation of TRPV5 reduces renal calcium oxalate deposition in rat via decreasing urinary calcium excretion.
Zeng T; Duan X; Zhu W; Liu Y; Wu W; Zeng G
Urolithiasis; 2018 Jun; 46(3):271-278. PubMed ID: 28776078
[TBL] [Abstract][Full Text] [Related]
19. Structural basis of TRPV5 regulation by physiological and pathophysiological modulators.
Fluck EC; Yazici AT; Rohacs T; Moiseenkova-Bell VY
Cell Rep; 2022 Apr; 39(4):110737. PubMed ID: 35476976
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
